Zoetis Inc receives Investment Bank Analyst Rating Update
- ByInvesting.com-
Symbol | Exchange | Currency |
---|
Zoetis Inc (NYSE: ZTS) has reported Q2 FY22 revenue of $2.05 billion, an increase of 5% Y/Y, almost in line with the consensus of $2.04Adjusted EPS was $1.20, +1% Y/Y, missing the...
Investing.com - Zoetis Inc (NYSE:ZTS) reported second quarter earnings that missed analysts' expectations on Thursday and revenue that topped forecasts. The firm reported...
Many people have marked Valentine's Day, Feb. 14, on their calendars. The annual festivity has evolved to one of the year’s most lucrative shopping seasons in the US....
So far in 2021, consumer spending in the U.S has been strong. According to the metrics released Aug. 31, the Conference Board Consumer Confidence Index was “113.8, down from...
Recent days brought new all-time-highs to the S&P 500 and NASDAQ 100, which are up about 14% and 12%, respectively, in 2021. Meanwhile, the Dow Jones Industrial Average, which...
Zoetis Inc. is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health technology. The Company has a business, commercializing products across eight core species: dogs, cats and horses (collectively, companion animals) and cattle, swine, poultry, fish and sheep (collectively, livestock); and within product categories such as vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. The Company operate its business through two segments: the United States and International. Within each of these operating segments, it offers a product portfolio for both companion animal and livestock customers. The Company market its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America, and its products are sold in more than 100 countries.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
---|---|---|---|---|---|
Moving Averages | Strong Buy | Buy | Sell | Strong Sell | Neutral |
Technical Indicators | Strong Buy | Strong Buy | Strong Sell | Neutral | Strong Sell |
Summary | Strong Buy | Strong Buy | Strong Sell | Sell | Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
---|---|---|---|---|---|---|---|---|---|
182.20 | 185.00 | 181.00 | -0.20 | -0.11% | 132.54K | London | |||
165.26 | 166.92 | 164.74 | +1.26 | +0.77% | 9.60M | London | |||
161.48 | 161.60 | 158.40 | +1.95 | +1.22% | 2.81M | London | |||
34.95 | 34.95 | 34.90 | 0.00 | 0.00% | 0.00 | London | |||
136.00 | 136.00 | 136.00 | 0.00 | 0.00% | 0.00 | London | |||
4,948.00 | 4,962.00 | 4,922.00 | +28.0 | +0.57% | 39.06K | London | |||
11,655.00 | 11,695.00 | 11,450.00 | +225.0 | +1.97% | 9.26K | London | |||
838.00 | 841.00 | 826.50 | +5.00 | +0.60% | 76.23K | London | |||
1,026.00 | 1,078.00 | 1,020.00 | -29.0 | -2.75% | 80.39K | London | |||
83.37 | 84.79 | 82.96 | +0.37 | +0.45% | 5.61M | London | |||
6,650.00 | 6,682.00 | 6,592.00 | +40.0 | +0.60% | 100.76K | London | |||
189.20 | 189.80 | 186.40 | +1.90 | +1.01% | 97.24K | London | |||
2.11 | 2.11 | 2.11 | +0.01 | +0.67% | 1.13M | London | |||
120.30 | 121.65 | 119.55 | -0.90 | -0.74% | 162.96K | London | |||
41.76 | 41.76 | 41.76 | +8.00 | +23.36% | 1.25M | London |